Overcoming Barriers to Delivering Large Molecules to the Brain episode artwork

EPISODE · Jun 5, 2024 · 18 MIN

Overcoming Barriers to Delivering Large Molecules to the Brain

from The Bio Report · host Levine Media Group

One of the challenges of treating neurodegenerative diseases is delivering therapies across the blood-brain barrier. Aliada Therapeutics is developing therapies that use its platform technology that enables the delivery of large molecules, like antibodies, across that barrier. Its lead program is in development to treat Alzheimer’s disease. We spoke to John Dunlop, chief scientific officer of Aliada, about its platform technology, its origins at Johnson & Johnson’s Janssen, and the company’s partnering strategy for leveraging the technology.

John Dunlop, chief scientific officer of Aliada, discusses its platform technology, its origins at Johnson & Johnson’s Janssen, and the company’s partnering strategy for leveraging the technology.

NOW PLAYING

Overcoming Barriers to Delivering Large Molecules to the Brain

0:00 18:14

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Bio Report?

This episode is 18 minutes long.

When was this The Bio Report episode published?

This episode was published on June 5, 2024.

What is this episode about?

One of the challenges of treating neurodegenerative diseases is delivering therapies across the blood-brain barrier. Aliada Therapeutics is developing therapies that use its platform technology that enables the delivery of large molecules, like...

Can I download this The Bio Report episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!